Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice

EDUARDO MUÑOZ BLANCO2026-01-292026-01-29202110.1016/j.mcn.2020.1035832-s2.0-85098131499https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/32749Cell BiologyCellular and Molecular NeuroscienceMolecular BiologyNeuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned miceresearch article